• br Implementation of sacubitril valsartan into clinical prac

  2023-07-24

  

  Implementation of sacubitril/valsartan into clinical practice Following on from the results of PARADIGM-HF, sacubitril/valsartan was given regulatory approval for use in patients who conform to the main inclusion criteria of the trial; NYHA functional class II–IV, reduced left ventricular ejectio

• br Role of AR in models of neointima formation Investigation

  2023-07-24

  

  Role of AR in models of neointima formation Investigations into the pathogenesis of lesion formation have often used acute models of mechanical damage to assess the mechanisms regulating the fibro-proliferative response to arterial injury. Models of acute injury used for this purpose include: lig

• br Introduction Diabetes mellitus DM is a chronic metabolic

  2023-07-24

  

  Introduction Diabetes mellitus (DM) is a chronic metabolic disorder characterized by elevated levels of glucose in the blood. Type 1 diabetes is characterized by insufficient insulin production and needs a daily administration of insulin. Actually, no prevention is known for Type 1 diabetes. Type

• The present study determined the effect of DCA on

  2023-07-24

  

  The present study determined the effect of DCA on VSMC calcification in vitro and in atherosclerotic ApoE-/- mice in vivo. We found that Annexin V-Cy3 Apoptosis Kit Plus non-toxic concentrations of DCA, did not affect VSMC viability, induced calcification of VSMC in culture and increased atheroscle

• br Preliminary remarks Expression of the

  2023-07-24

  

  Preliminary remarks Expression of the transcription factor aryl hydrocarbon receptor (AHR) and the AHR-repressor (AHRR) are both strikingly high in the Fludara of barrier organs skin and gut [1,2]. It is generally assumed that this reflects their role in linking environmental factors to an adapt

• SB 258719 hydrochloride Cancers that responded to immune che

  2023-07-24

  

  Cancers that responded to immune checkpoint inhibitors were shown to present a type I interferon (IFN) signature in the TME 33, 34. Type I IFNs positively regulate the expression of tumor antigens and their crosspresentation by DCs to tumoricidal CTLs. Furthermore, CD8+ T cell develops full effector

• It is also possible that adrenoceptor

  2023-07-24

  

  It is also possible that α2-adrenoceptor activation may inhibit glutamate accumulation by upregulating the glutamate-buffering activity of Müller GLP-2 (rat) through EAAT1 or adjusting EAAT2 in bipolar cells, as well as the NMDA receptor. Therefore, we investigated whether topical administration of

• br Materials and methods br Results br Discussion

  2023-07-24

  

  Materials and methods Results Discussion In this study, we have demonstrated that the adiponectin system (genes and proteins) is present in the porcine endometrium (epithelial glandular cells, luminal epithelial cyclohexamide and stromal cells) and myometrium (longitudinal and circular mus

• br Acknowledgements This work was supported

  2023-07-24

  

  Acknowledgements This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (IRT_14R28), the National Basic Research Program of China (973) (Grant No.: 2013CB733602), the Major Research Plan of the National Natural Science Foundation of C

• Endogenous adenosine systems have largely been implicated in

  2023-07-24

  

  Endogenous adenosine systems have largely been implicated in drug actions by the demonstration that caffeine (non-selective A1R and A2AR antagonist) (see Section The issue of caffeine), in doses up to 7.5–10mg/kg, inhibits antinociception, and when this occurs, it Gefitinib is generally also seen w

• In another study authors found that ADORA were present on

  2023-07-24

  

  In another study, authors found that ADORA1 were present on the intrinsically photosensitive retinal ganglion Bikinin (ipRGCs), and application of adenosine to rat retinas reduced light-evoked spiking of ipRGCs through suppression of a cAMP-mediated pathway (Sodhi and Hartwick, 2014). The ipRGCs ar

• br Introduction Myasthenia gravis MG is an

  2023-07-24

  

  Introduction Myasthenia gravis (MG) is an autoimmune disease characterised by failure of transmission at the neuromuscular junction (NMJ). In 80–85% of myasthenia gravis patients, the disease is mediated by antibodies to the nicotinic 1670 receptor (AChR; (Lindstrom et al., 1976). Many investigat

• AZD5363 Very recently Niessen et al have described the resen

  2023-07-24

  

  Very recently, Niessen et al. have described the resensitizing effect of MB327 on nAChR performing solid-supported membrane (SSM)-based electrophysiological experiments (Niessen et al., 2016) using plasma membrane preparations obtained from Torpedo californica. These findings validated and underline

• In summary we could identify and experimentally confirm two

  2023-07-24

  

  In summary, we could identify and experimentally confirm two novel SBEs within the 5-LO promoter and we were able to demonstrate that TGFβ and SMADs stimulate 5-LO promoter activity. Moreover, an elevated 5-LO expression has been linked to different forms of leukaemia. Therefore, the influence of ML

• br Author contributions br Competing interests

  2023-07-21

  

  Author contributions Competing interests Transparency document Acknowledgments This research was funded by a TOP ZonMW grant (40-00812-98-10054) to R.O.E., a DFG grant (KR4391/1-1) and IZKF Erlangen grant (J36) to A.K. and supported in part by Centro de Investigación Biomédica en Red de

14960 records 312/998 page Previous Next First page 上5页 311312313314315 下5页 Last page